Quisel John D insider trades
Quisel John D has filed 26 Form 4s with the SEC that we hold, for Disc Medicine, Inc. (IRON) (Chief Executive Officer, Director) and Gossamer Bio, Inc. (GOSS) (Director). Across all of them we count 0 purchases worth $0 and 27 sales worth $17.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 14 sales ($12.0M). The largest single trade was a sale of 31,207 shares of Disc Medicine, Inc. worth $1.7M, dated 2025-07-09. The first filing on our record is dated 2023-01-03 and the latest 2026-09-25.
Disc Medicine, Inc. (IRON)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-16 | S, sale reported on Form 4 | 219 | $14.2K | 2024-12-18 |
| 2024-12-16 | S, sale reported on Form 4 | 500 | $33.6K | 2024-12-18 |
| 2024-12-16 | S, sale reported on Form 4 | 6,305 | $418.3K | 2024-12-18 |
| 2024-12-16 | S, sale reported on Form 4 | 5,767 | $378.2K | 2024-12-18 |
| 2024-12-23 | S, sale reported on Form 4 | 12,194 | $769.7K | 2024-12-26 |
| 2024-12-23 | S, sale reported on Form 4 | 4,212 | $268.7K | 2024-12-26 |
| 2024-12-23 | S, sale reported on Form 4 | 3,414 | $213.0K | 2024-12-26 |
| 2024-12-30 | S, sale reported on Form 4 | 1,900 | $118.6K | 2025-01-02 |
| 2024-12-30 | S, sale reported on Form 4 | 11,112 | $687.5K | 2025-01-02 |
| 2025-02-18 | S, sale reported on Form 4 | 5,574 | $304.2K | 2025-02-20 |
| 2025-07-03 | S, sale reported on Form 4 | 5,200 | $286.5K | 2025-07-08 |
| 2025-07-09 | S, sale reported on Form 4 | 31,207 | $1.7M | 2025-07-11 |
| 2025-07-09 | S, sale reported on Form 4 | 3,593 | $201.9K | 2025-07-11 |
| 2025-12-11 | S, sale reported on Form 4 | 2,419 | $220.1K | 2025-12-15 |
| 2025-12-11 | S, sale reported on Form 4 | 4,337 | $399.9K | 2025-12-15 |
| 2025-12-11 | S, sale reported on Form 4 | 16,356 | $1.5M | 2025-12-15 |
| 2025-12-11 | S, sale reported on Form 4 | 16,888 | $1.6M | 2025-12-15 |
| 2026-02-17 | S, sale reported on Form 4 | 13,264 | $833.8K | 2026-02-17 |
| 2026-06-18 | S, sale reported on Form 4 | 1,551 | $111.1K | 2026-06-23 |
| 2026-06-18 | S, sale reported on Form 4 | 9,522 | $673.2K | 2026-06-23 |
| 2026-06-18 | S, sale reported on Form 4 | 22,927 | $1.6M | 2026-06-23 |
| 2026-07-13 | S, sale reported on Form 4 | 9,704 | $720.7K | 2026-07-14 |
| 2026-07-13 | S, sale reported on Form 4 | 16,896 | $1.3M | 2026-07-14 |
| 2026-07-13 | S, sale reported on Form 4 | 6,400 | $486.7K | 2026-07-14 |
| 2026-08-17 | S, sale reported on Form 4 | 8,400 | $656.1K | 2026-08-18 |
| 2026-08-17 | S, sale reported on Form 4 | 12,712 | $1.0M | 2026-08-18 |
| 2026-08-17 | S, sale reported on Form 4 | 11,888 | $949.2K | 2026-08-18 |
Gossamer Bio, Inc. (GOSS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1586788) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms